Home > Insider Trading > Filing (0001415889-24-010473)

Filing Details

Accession Number:: 0001415889-24-010473
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2024-04-05 21:32:12
Reporting Period:: 2024-04-03

Accepted Time:: 2024-04-05 21:32:12
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1831828	Vera Therapeutics Inc.	VERA	Pharmaceutical Preparations (2834)	812744449

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1872792	Sean Grant	C/O Vera Therapeutics, Inc. 8000 Marina Boulevard, Suite 120 Brisbane CA 94005	Chief Financial Officer	No	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Class A Common Stock	Acquisiton	2024-04-03	99,828	$14.87	166,165	No	4	M	Direct
Class A Common Stock	Disposition	2024-04-03	69,831	$40.05	96,334	No	4	S	Direct
Class A Common Stock	Disposition	2024-04-03	10,988	$38.65	85,346	No	4	S	Direct
Class A Common Stock	Disposition	2024-04-03	11,648	$38.13	73,698	No	4	S	Direct
Class A Common Stock	Disposition	2024-04-03	7,361	$39.25	66,337	No	4	S	Direct
Class A Common Stock	Disposition	2024-04-03	78	$38.20	257	No	4	S	Indirect	By Roth IRA
Class A Common Stock	Disposition	2024-04-03	80	$39.22	177	No	4	S	Indirect	By Roth IRA
Class A Common Stock	Disposition	2024-04-03	177	$40.06	0	No	4	S	Indirect	By Roth IRA
Class A Common Stock	Disposition	2024-04-03	387	$38.22	1,233	No	4	S	Indirect	As custodian for UTMA account
Class A Common Stock	Disposition	2024-04-03	366	$39.19	867	No	4	S	Indirect	As Custodian for UTMA account
Class A Common Stock	Disposition	2024-04-03	867	$40.06	0	No	4	S	Indirect	As Custodian for UTMA account
Class A Common Stock	Disposition	2024-04-03	672	$38.22	2,144	No	4	S	Indirect	By IRA
Class A Common Stock	Disposition	2024-04-03	639	$39.19	1,505	No	4	S	Indirect	By IRA
Class A Common Stock	Disposition	2024-04-03	1,505	$40.06	0	No	4	S	Indirect	By IRA
Class A Common Stock	Disposition	2024-04-03	201	$38.23	656	No	4	S	Indirect	By Spouse's IRA
Class A Common Stock	Disposition	2024-04-03	203	$39.20	453	No	4	S	Indirect	By Spouse's IRA
Class A Common Stock	Disposition	2024-04-03	453	$40.05	0	No	4	S	Indirect	By Spouse's IRA
Class A Common Stock	Disposition	2024-04-03	3,112	$38.22	14,909	No	4	S	Indirect	By Trust
Class A Common Stock	Disposition	2024-04-03	2,944	$39.19	11,965	No	4	S	Indirect	By Trust
Class A Common Stock	Disposition	2024-04-03	6,965	$40.06	5,000	No	4	S	Indirect	By Trust

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Indirect	By Roth IRA
No	4	S	Indirect	By Roth IRA
No	4	S	Indirect	By Roth IRA
No	4	S	Indirect	As custodian for UTMA account
No	4	S	Indirect	As Custodian for UTMA account
No	4	S	Indirect	As Custodian for UTMA account
No	4	S	Indirect	By IRA
No	4	S	Indirect	By IRA
No	4	S	Indirect	By IRA
No	4	S	Indirect	By Spouse's IRA
No	4	S	Indirect	By Spouse's IRA
No	4	S	Indirect	By Spouse's IRA
No	4	S	Indirect	By Trust
No	4	S	Indirect	By Trust
No	4	S	Indirect	By Trust

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Class A Common Stock	Stock Option (right to buy)	Disposition	2024-04-03	99,828	$0.00	99,828	$14.87

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
80,172		2031-07-12	No	4	M	Direct

Footnotes

Includes 1,939 shares of Class A Common Stock acquired under the Issuer's 2021 Employee Stock Purchase Plan on March 13, 2024.
The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $39.50 to $40.36, inclusive. The Reporting Person will provide upon request to the staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each separate price.
The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $38.25 to $39.225, inclusive. The Reporting Person will provide upon request to the staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each separate price.
The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $38.00 to $38.52, inclusive. The Reporting Person will provide upon request to the staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each separate price.
The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $39.075 to $39.35, inclusive. The Reporting Person will provide upon request to the staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each separate price.
The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $37.70 to $38.64, inclusive. The Reporting Person will provide upon request to the staff of the Securities and Exchange Commission, the Issuer or anysecurity holder of the Issuer, full information regarding the number of shares sold at each separate price.
The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $38.75 to $39.67, inclusive. The Reporting Person will provide upon request to the staff of the Securities and Exchange Commission, the Issuer or anysecurity holder of the Issuer, full information regarding the number of shares sold at each separate price.
The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $39.82 to $40.355, inclusive. The Reporting Person will provide upon request to the staff of the Securities and Exchange Commission, the Issuer or anysecurity holder of the Issuer, full information regarding the number of shares sold at each separate price.
The shares were acquired through a custodial account established for an immediate family member of the Reporting Person pursuant to the Uniform Transfers to Minors Act, for which the Reporting Person serves as a custodian.
The Reporting Person disclaims beneficial ownership of these shares, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of these shares for purposes of Section 16 or for any other purpose.
1/4 of 180,000 shares subject to the option vested on July 12, 2022, and 1/48 of the shares vest monthly thereafter.